CPI and the University of Liverpool join forces to create the Microbiome and Infectious Disease Innovation Hub. Liverpool City Region is set to become a global powerhouse in tackling deadly diseases and improving wellbeing.
More than £1m of Life Sciences Innovation Zone funding will support the creation of a Microbiome and Infectious Disease Innovation Hub (MaID) to harness the University of Liverpool’s expertise in the rapidly expanding field.
The University of Liverpool and CPI have signed a formal Memorandum of Understanding (MoU) to progress the project which will provide varying levels of support to 60 innovative businesses over 3 years, including in-depth consultancy, access to labs, experimental design, data analysis, and regulatory and commercial advice.
Leveraging CPI’s facilities and deep expertise, MaID will provide end-to-end support for businesses and organisations seeking to de-risk and accelerate microbiome and phage therapeutics to market.
